DEA Chief Administrative Law Judge Derek C. Julius paused the federal cannabis rescheduling hearing this week to consider adding a new Government Accountability Office (GAO) report to the hearing.
The cannabis rescheduling hearing officially ended in July, and post-hearing briefs were filed in August. Until this week, the last step anticipated in the hearing process was the judge’s final ruling.
The National Drug & Alcohol Screening Association and the advocacy group DUID Victim Voices submitted the motion to include the GAO report on September 28. Officials and other interested parties have until October 13 to respond.
Cannabis stock prices sank this week after reports that the rescheduling hearing was delayed.
The report found that the DEA and FDA both lack procedures for properly evaluating and scheduling substances, and recommended that the agencies adopt policies to remedy the situation.
According to an excerpt from the GAO report, “DEA and FDA have policies that address aspects of the scheduling process, including a memorandum of understanding (MOU) for sharing information; however, these policies have gaps. For example, DEA does not have policies that identify roles, responsibilities, and procedures related to scheduling. FDA does not have policies or procedures specifying how its staff are to conduct evaluations or develop recommendations.
Interested parties have until October 13 to respond to the motion. Judge Julius will weigh whether the GAO report should be added to the hearing.
The hearing itself concluded in July, with post-hearing briefs filed in August.
The federal cannabis rescheduling proceeding remains pending before Judge Julius.
DEA Wraps Up Rescheduling Hearing The Drug Enforcement Administration concluded its administrative hearing on marijuana rescheduling on July 15, 2026,…
Manitoba Bill Would Let Cannabis Stores Uncover Windows The Manitoba government is proposing new rules that would let cannabis stores…
New Registry Portal Launches September 30 The Hawaii Department of Health, Office of Medical Cannabis Control and Regulation (OMCCR), will…
Pharma Packaging Offers A Roadmap Medical cannabis companies developing new products or redesigning packaging are being advised to look beyond…
Treasury and IRS Add Marijuana Tax Guidance to Priority Plan Federal officials say they will prioritize issuing tax-related guidance for…
City Reveals It Has Never Audited Cannabis Gross Receipts Officials in Antioch, California, have acknowledged that the city has never…
